Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenon

Author： Marasini B Massarotti M Bottasso B Coppola R Papa N Del Maglione W Comina DP Maioli C

ISSN： 0300-9742

Source： Scandinavian Journal of Rheumatology, Vol.33, Iss.4, 2004-07, pp. : 253-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antioxidant status after iloprost treatment in patients with Raynaud’s phenomenon secondary to systemic sclerosis

By Balbir-Gurman Alexandra Braun-Moscovici Yolanda Livshitz Vladimir Schapira Daniel Markovits Doron Rozin Alexander Boikaner Tatiana Nahir A.

Clinical Rheumatology, Vol. 26, Iss. 9, 2007-09 ,pp. : 1517-1521

Springer Publishing Company

Access to resources Recommend Favorite

Importance of identification and treatment of Raynaud’’s phenomenon

By Frech Tracy Sawitzke Allen

Future Rheumatology, Vol. 2, Iss. 5, 2007-10 ,pp. : 521-525

Future Medicine

Access to resources Recommend Favorite

Comparison of thermography and laser Doppler imaging in the assessment of Raynaud's phenomenon

By Clark S. Dunn G. Moore T. Jayson M. King T.A. Herrick A.L.

Microvascular Research, Vol. 66, Iss. 1, 2003-07 ,pp. : 73-76

Elsevier

Access to resources Recommend Favorite

Raynaud's Phenomenon: State of the Art 1998

By Ho Meilien Belch Jill J.F.

Scandinavian Journal of Rheumatology, Vol. 27, Iss. 5, 1998-10 ,pp. : 319-322

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of Raynaud's phenomenon in young Greek males

By Tzilalis Vassilios Panagiotopoulos Nikolaos Papatheodorou George Rallis Efstathios Kassimos Dimitrios

Clinical Rheumatology, Vol. 30, Iss. 1, 2011-01 ,pp. : 57-59

Springer Publishing Company

Access to resources Recommend Favorite